This inventor holds 2 USPTO granted patents. Top assignee: Amgen Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Timothy Patrick Riley
Introduction
Timothy Patrick Riley is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work focuses on innovative solutions for treating inflammatory diseases.
Latest Patents
Timothy holds a patent for "IL-10 muteins and fusion proteins thereof." This patent relates to muteins of IL-10 that are stable as monomers, antigen binding proteins that bind to TREM-1, and antigen binding proteins comprising IL-10 muteins and antigen binding moieties, such as anti-TREM-1 antibodies. The disclosure also provides methods for treating inflammatory diseases, including inflammatory bowel disease and ulcerative colitis, using these compositions. He has 1 patent to his name.
Career Highlights
Timothy is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout his career, Timothy has collaborated with notable colleagues, including Ian Foltz and Ming Zhang. These collaborations have fostered a productive environment for innovation and advancement in their respective fields.
Conclusion
Timothy Patrick Riley's contributions to biotechnology and his innovative patent for IL-10 muteins highlight his commitment to improving treatments for inflammatory diseases. His work continues to impact the medical community positively.